NextCure Inc $ 11.39 -0.15 (-1.3%)
Volume:
338,385
Avg Vol (1m):
255,304
Market Cap $:
313.83 Mil
Enterprise Value $:
26.51 Mil
PE Ratio:
0.00
PB Ratio:
1.01
Financial Strength | 5/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 74.88 | ||
Debt-to-Equity | 0.01 | ||
Debt-to-EBITDA | -0.12 | ||
Altman Z-Score | 22.23 | ||
Beneish M-Score | 0 | ||
WACC vs ROIC |
Profitability Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -142.49 | ||
Net Margin % | -123.5 | ||
ROE % | -11.03 | ||
ROA % | -10.32 | ||
ROC (Joel Greenblatt) % | -267.11 |
NXTC
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 1.01 | ||
PS Ratio | 13.64 | ||
EV-to-EBIT | -0.73 | ||
EV-to-EBITDA | -0.73 | ||
EV-to-Revenue | 1.04 | ||
Current Ratio | 51.73 | ||
Quick Ratio | 51.73 |
Dividend & Buy Back |
Current | Vs Industry | Vs History |
---|
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 1.02 | ||
Earnings Yield (Greenblatt) % | -139.26 |